mavorixafor will raise the degree or outcome of triazolam by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check. Check for adverse results of delicate CYP3A4 substrates if coadministered with mavorixafor (a weak CYP3A4 inhibitor).However, maybe you have a relapse of despair when you cease using your antidepressant. Tell your m